Stable Ischemic Heart Disease

被引:0
|
作者
Kones, Richard [1 ]
Rumana, Umme [1 ]
机构
[1] Cardiometab Res Inst, Houston, TX 77054 USA
关键词
Angina; Stable ischemic heart disease; Coronary artery disease; Myocardial oxygen balance; Cardiovascular risk assessment; Silent ischemia; Nitrates; beta-Blockers; Calcium channel blockers; CORONARY-ARTERY-DISEASE; ACUTE MYOCARDIAL-INFARCTION; 36 METABOLIC EFFICIENCY; ASSOCIATION TASK-FORCE; PRACTICE GUIDELINES; AMERICAN-COLLEGE; ANGINA-PECTORIS; SILENT ISCHEMIA; LESS ISCHEMIA; DAILY-LIFE;
D O I
10.1016/j.ccl.2014.04.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Classical angina refers to typical substernal discomfort triggered by effort or emotions, relieved with rest or nitroglycerin. The well-accepted pathogenesis is an imbalance between oxygen supply and demand. Goals in therapy are improvement in quality of life by limiting the number and severity of attacks, protection against future lethal events, and measures to lower the burden of risk factors to slow disease progression. New pathophysiological data, drugs, as well as conceptual and technological advances have improved patient care over the past decade. Behavioral changes to improve diets, increase physical activity, and encourage
引用
收藏
页码:333 / +
页数:20
相关论文
共 50 条
  • [31] Stable Coronary Syndromes The Case for Consolidating the Nomenclature of Stable Ischemic Heart Disease
    Berry, Colin
    [J]. CIRCULATION, 2017, 136 (05) : 437 - 439
  • [32] Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes
    Everett, Brendan M.
    Brooks, Maria Mori
    Vlachos, Helen E. A.
    Chaitman, Bernard R.
    Frye, Robert L.
    Bhatt, Deepak L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (07): : 610 - 620
  • [33] Is it expendient to prescribe ACE inhibitors in stable ischemic heart disease?
    Makolkin, VI
    [J]. KARDIOLOGIYA, 2003, 43 (04) : 27 - 29
  • [34] Diagnosis of Stable Ischemic Heart Disease: Recommendations from the ACP
    Devitt, Michael
    [J]. AMERICAN FAMILY PHYSICIAN, 2013, 88 (07) : 469 - 470
  • [35] Percutaneous coronary interventions for stable ischemic heart disease in Italy
    De Servi, Stefano
    Olivari, Zoran
    Crimi, Gabriele
    Marino, Marcello
    Alberti, Luca P.
    Tagliabue, Elena
    Leonardi, Sergio
    [J]. JOURNAL OF CARDIOVASCULAR MEDICINE, 2019, 20 (11) : 762 - 767
  • [36] Development of a TIMI Risk Score for Stable Ischemic Heart Disease
    Bohula, Erin A.
    Bonaca, Marc P.
    Aylward, Philip E.
    De Ferrari, Gaetano M.
    He, Ping
    Lewis, Basil S.
    Merlini, Piera
    Murphy, Sabina A.
    Sabatine, Marc S.
    Scirica, Benjamin M.
    Braunwald, Eugene
    Morrow, David A.
    [J]. CIRCULATION, 2015, 132
  • [37] Myocardial bioenergetic profiling in patients with stable ischemic heart disease
    Jones, Richard E.
    Prasad, Sanjay K.
    [J]. NATURE CARDIOVASCULAR RESEARCH, 2023, 2 (08): : 716 - 717
  • [38] REPLY: Beta-Blockers in Stable Ischemic Heart Disease
    Godoy, Lucas C.
    Farkouh, Michael E.
    Ko, Dennis T.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (18) : E169 - E169
  • [39] Should patients with stable ischemic heart disease undergo revascularization?
    Chenier, Michael
    Lincoff, A. Michael
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2016, 83 (08) : 567 - 570
  • [40] Diagnosis and risk stratification of women with stable ischemic heart disease
    Isiadinso, Ijeoma
    Shaw, Leslee J.
    [J]. JOURNAL OF NUCLEAR CARDIOLOGY, 2016, 23 (05) : 986 - 990